Kramer Levin represented Leading Pharma, LLC in its December 31, 2014 acquisition of substantially all of the assets of Excellium Pharmaceutical, Inc., as well as in connection with a private equity offering by Leading’s parent company. The Kramer Levin team was led by Corporate partner Steven M. Goldman and associate Jodi Rosensaft, and included Corporate partner James A. Grayer and associates Alexander Traum and Julia Papastavridis. Howard J. Rothman, Pamela M. Capps, Barry Herzog and Jason Tomitz advised on Tax and structuring matters, and Tzvi Rokeach and Joshua S. Winefsky advised on Real Estate matters.